全文获取类型
收费全文 | 12676篇 |
免费 | 709篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 103篇 |
儿科学 | 290篇 |
妇产科学 | 253篇 |
基础医学 | 1525篇 |
口腔科学 | 216篇 |
临床医学 | 987篇 |
内科学 | 3367篇 |
皮肤病学 | 225篇 |
神经病学 | 1339篇 |
特种医学 | 327篇 |
外科学 | 1870篇 |
综合类 | 42篇 |
预防医学 | 653篇 |
眼科学 | 234篇 |
药学 | 809篇 |
中国医学 | 17篇 |
肿瘤学 | 1209篇 |
出版年
2023年 | 85篇 |
2022年 | 172篇 |
2021年 | 390篇 |
2020年 | 194篇 |
2019年 | 291篇 |
2018年 | 330篇 |
2017年 | 229篇 |
2016年 | 314篇 |
2015年 | 302篇 |
2014年 | 442篇 |
2013年 | 575篇 |
2012年 | 835篇 |
2011年 | 868篇 |
2010年 | 498篇 |
2009年 | 429篇 |
2008年 | 710篇 |
2007年 | 785篇 |
2006年 | 748篇 |
2005年 | 710篇 |
2004年 | 650篇 |
2003年 | 577篇 |
2002年 | 515篇 |
2001年 | 268篇 |
2000年 | 280篇 |
1999年 | 224篇 |
1998年 | 130篇 |
1997年 | 117篇 |
1996年 | 109篇 |
1995年 | 86篇 |
1994年 | 80篇 |
1993年 | 49篇 |
1992年 | 147篇 |
1991年 | 131篇 |
1990年 | 118篇 |
1989年 | 108篇 |
1988年 | 94篇 |
1987年 | 92篇 |
1986年 | 80篇 |
1985年 | 81篇 |
1984年 | 90篇 |
1983年 | 68篇 |
1982年 | 43篇 |
1981年 | 38篇 |
1980年 | 37篇 |
1979年 | 50篇 |
1978年 | 39篇 |
1977年 | 21篇 |
1976年 | 31篇 |
1974年 | 25篇 |
1973年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
Emilio Abecia Begoña Martínez-Jarreta Yolanda Casalod Blanca Bell Isabel Pinilla Francisco M. Honrubia 《International ophthalmology》1996,20(1-3):79-82
Purpose: To investigate possible associations between genetic markers and Primary Open-Angle Glaucoma (POAG). Methods: A number of genetic markers were typed in 84 unrelated patients with POAG and compared with a random sample of healthy individuals. The markers were Transferrin, Group Specific Component, G1m (1), G1m (2) and G3m (5) Allotypes, Adenylate Kinase, Adenosin Deaminase, Glyoxalase I and Acid Phosphatase and PCR-based markers HLA-DQA1 and D1S80. Results: No significant differences were found except the strong association between the group of POAG patients and Acid Phosphatase ACP*C allele (2 = 32.86; p < 0.0001). Conclusions: Since Acid Phosphatase gene is localized to chromosome 2p23, this result could be a first comprehensive step in the localization of POAG genes. 相似文献
92.
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated. 总被引:1,自引:0,他引:1
R J Motzer S C Gulati J P Crown S Weisen M Doherty H Herr W Fair J Sheinfeld P Sogani P Russo 《Cancer》1992,69(2):550-556
Therapy with high-dose carboplatin plus etoposide-based chemotherapy plus autologous bone marrow rescue (AUBMR) was administered to 29 patients with advanced germ cell tumors (GCT) refractory to cisplatin-based chemotherapy. Two groups of patients with refractory disease were treated. Sixteen patients had been identified as "poor risk" at diagnosis and had an inappropriately slow decline of serum tumor markers after two cycles of induction cisplatin-based therapy (Group A). In addition, 13 patients were treated who had never had a complete response (CR) or had relapses after ifosfamide-based salvage chemotherapy (Group B). Patients in Group A were treated with high-dose carboplatin etoposide, and patients in Group B received high-dose carboplatin, etoposide, and cyclophosphamide. Fifteen of 29 (52%) patients had a CR (9, Group A; 6, Group B). The patients in Group A had fewer hematologic toxic effects, and the median number of days from day 0 to a granulocyte count greater than 0.5/microliters was 16 and to a platelet count of more than 50/microliters was 15, compared with 22 days and 23 days in Group B, respectively. There were fewer episodes of culture-positive sepsis in Group A (12%) compared with Group B (26%), and the only treatment-related death occurred in Group B. Therapy with high-dose carboplatin plus etoposide-based chemotherapy plus AUBMR is effective for patients with GCT refractory to regimens of cisplatin with or without ifosfamide. Early use of high-dose chemotherapy reduces hematologic toxic effects and allows patients to start treatment in a more predictable fashion after cytoreduction, rather than when the disease is progressing rapidly. 相似文献
93.
M. Strolin Benedetti A. Russo P. Marrari P. Dostert 《Journal of neural transmission (Vienna, Austria : 1996)》1991,86(3):191-203
Summary Concentrations of the sulfur-containing amino acids methionine, homocysteic acid, cysteic acid and taurine were measured in brain structures of young and old Wistar rats in an attempt to etablish a possible link between the increase in oxidative stress with ageing and changes in tissue levels of these amino acids. Contrary to data reported by others, in all brain structures of young and old rats homocysteic acid levels could not be quantified. Compared with young rats, in old animals taurine and methionine concentrations significantly decreased in striatum and cortex; decreased taurine levels were also found in nucleus accumbens and cerebellum and lower concentrations of methionine were found in midbrain, hippocampus and pons-medulla. Cysteic acid levels either did not change or significantly increased in cortex and hippocampus. These results are discussed taking into account the biosynthesis of sulfur-containing amino acids in rat brain and the decrease in glutathione in relation to oxidative stress with ageing.Changes in aspartic acid, glutamic acid, serine, glutamine, glycine and GABA concentrations with ageing were also determined in the same brain structures and were in good agreement with those previously reportedAbbreviations
H
2O2
hydrogen peroxide
-
MAO
monoamine oxidase
-
GSHP
glutathione peroxidase
-
PAPS
3-phosphoadenosine-5-phosphosulfate
-
OPA
O-phthaldialdehyde
-
HPLC
high performance liquid chromatography
-
Asp
aspartic acid
-
CA
cysteic acid
-
CSA
cysteine sulfinic acid
-
Cys
cysteine
-
GABA
-aminobutyric acid
-
Gln
glutamine
-
Glu
glutamic acid
-
Gly
glycine
-
HCA
homocysteic acid
-
Met
methionine
-
Ser
serine
-
Tau
taurine 相似文献
94.
B Memoli C Libetta M Sabbatini G Conte D Russo U Giani D Capone V E Andreucci 《Kidney international》1991,40(6):1134-1140
The aim of this study was the evaluation, in healthy subjects, of the renal functional reserve (RFR), that is, the GFR increase induced by a combined infusion of amino acids (AA) and dopamine (D), in conditions of extracellular volume depletion caused by diuretic administration. In particular, this study was undertaken: a) to evaluate whether and to which extent, AA + D can reverse the functional GFR impairment induced by salt depletion, without volume restoration; b) to study whether any relationship may be found between the GFR in normal condition (the so-called "resting" GFR), and/or the renal functional reserve and the GFR impairment induced by salt depletion, in order to understand the role of both "resting" GFR and RFR in the degree of renal dysfunction induced by salt depletion. In control conditions the i.v. infusion of AA + D significantly increased RPF (+ 41% vs. baseline period) with a mean absolute increase of 211 ml/min. A similar pattern was observed in GFR behavior (+31.5% with 34 ml/min of mean absolute increase). A significant inverse exponential relationship was observed between GFR before AA + D i.v. infusion ("resting" GFR) and renal functional reserve (P less than 0.05), suggesting that, in normal conditions, these inversely related parameters may widely vary according to the tone of the glomerular arterioles. Following salt depletion, we observed a variable degree of GFR impairment. Both GFR and RPF were significantly decreased (-25.9%, P less than 0.05 and -29%, P less than 0.05, respectively).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
95.
96.
Russo RM 《Urban health》1982,11(6):45-48
Poverty has a major impact on the nation's state of health. Although its effects are difficult to separate from that of old age and the problems of minorities, there are definite correlations between indicators of economic well being and mortality/morbidity rates United States vital statistics and extensive health interview surveys provide ample documentation of the role of poverty as a health determinant. The success the Indian Health Service has had in lowering mortality rates mirrors the nation's as a whole and demonstrates what can be done if socioeconomic conditions, as well as health care delivery, is improved. The message should not be lost sight of it this era of cutbacks in social programs. 相似文献
97.
Abnormal visual event-related potentials in obsessive-compulsive disorder without panic disorder or depression comorbidity 总被引:4,自引:0,他引:4
Visual event-related potentials and spline map topography during a discriminative response task (DRT) were studied in 8 obsessive-compulsive disorder (OCD) patients without comorbidity for panic disorder or depression and in 12 age-matched controls. In the DRT task (like in a go/no-go task) the subject had to press a button when the target stimuli appeared and had to retain the response when the non-target stimulus appeared (vertical bars were intermixed with an equal probability of horizontals). OC patients had greater N1 latency than controls and their N1 and P3 amplitude was larger for the target stimuli, but not for non-target stimuli. In the normals, non-target stimuli (no-go task) produced a larger activation than target stimuli (go task). In the OCD patients the target stimuli produced the same large activation as the non-target. These findings are consistent with theories that consider OCD to be an attentional disorder deriving from a misallocating of cognitive resources. Moreover, spline map topography confirmed that P3 hyperactivation is localised principally on the frontal lobes. 相似文献
98.
99.
G Varuni Kondagunta Beverly Drucker Lawrence Schwartz Jennifer Bacik Stephanie Marion Paul Russo Madhu Mazumdar Robert J Motzer 《Journal of clinical oncology》2004,22(18):3720-3725
PURPOSE: To assess the efficacy and toxicity of bortezomib (Velcade; Milennium Pharmaceuticals Inc, Cambridge, MA; formerly PS-341) in patients with metastatic renal cell carcinoma (RCC). PATIENTS AND METHODS: Thirty-seven patients with metastatic RCC were treated with bortezomib. The first 25 patients enrolled onto the trial were treated with a dose of 1.5 mg/m2. The dose was decreased to 1.3 mg/m2 for the subsequent 12 patients, because more than 50% of the patients treated at the higher dose required dose reductions. Bortezomib was given by intravenous administration on a twice-weekly schedule for 2 weeks followed by 1 week without treatment until progression or unacceptable toxicity occurred. Twenty-three patients (62%) previously had undergone nephrectomy, and 19 patients (51%) had previously been treated with cytokine therapy. RESULTS: Of the 37 assessable patients, the best response was a partial response in four patients (11%; 95% CI, 3% to 25%) and stable disease in 14 patients (38%; 95% CI, 23% to 55%). The four patients with partial response experienced response durations of 8, 8+, 15+, and 20+ months. Grade 2 or 3 sensory neuropathy was present in 10 patients (53%) overall. One patient in the 1.5 mg/m2 group had grade 3 sensory neuropathy; no grade 3 sensory neuropathy was seen in the 1.3 mg/m2 group. CONCLUSION: The results of this trial suggest that bortezomib has an antitumor effect in individual patients with metastatic RCC. The small proportion of patients who achieved a partial response does not support routine use in metastatic RCC. Efforts to identify the molecular profile associated with clinical response or combination therapy with interferon alfa or other novel agents, may be considered. 相似文献
100.
Lorenzo Alonso Carrión Francisco Jesús González Sánchez Emilio Alba Conejo Esperanza Torres Sánchez 《Clinical & translational oncology》2004,6(8):462-467
Advanced stage ovarian cancer has a high rate of recurrence even after surgery followed by chemotherapy combining carboplatin
and a taxane. New strategies are currently under way to combat this situation and one of the most promising ones is based
on the knowledge that angiogenesis, the mechanism of formation of new blood vessels coupled with the degradation of the extracellular
matrix for metalloproteinases, could be crucial in the development of this tumor. The principal molecule implicated in angiogenesis
process of ovarian cancer is the vascular endothelial growth factor (VEGF). Several studies are now in progress to clarify
its role as a diagnostic tool or its therapeutic implication. Presently, there is no indication for the use of VEGF in a preliminary
diagnosis seeing that an increase in levels can be seen in both benign and malignant ovarian conditions. VEGF is also responsible
for an increase in vascular permeability and is directly related to symptoms such as ascites and pleural effusion, both of
which are frequent in ovarian cancer. Several papers have analised the role of VEGF as a prognostic factor and some of them
do confirm VEGF as an independent prognostic factor in ovarian cancer. VEGF and the metalloproteinase system coupled with
angiogenesis are currently being evaluated as therapeutic targets but no positive results have yet to be seen in this field.
相似文献